glp-1 agonists and anesthesia How should we approach patients on agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like AAOMS may update anesthesia guide

Therapeutic strategies aimed at inhibiting ferroptosissuch as employing antioxidants or iron chelatorsrepresent promising avenues for attenuating COPD progression

The objective of such research is to elucidate the molecular pathways, like the FAK-paxillin axis, that govern the repair of connective tissues

Ultimate support from your coaches: At Metabolic Research Center, we pair GLP-1 support with personalized coaching, practical nutrition guidance, and clinical oversight

Also known as Body Protection Compound-157, it is composed of 15 amino acids and is considered a peptidergic agent, meaning it has drug-like effects